Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Determination of System Suitability Criteria – V 2.0

Posted on By

Analytical Method Development: SOP for Determination of System Suitability Criteria – V 2.0

Standard Operating Procedure for Determining System Suitability Criteria in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/381/2025
Supersedes SOP/AMD/381/2022
Page No. Page 1 of 13
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2027

1. Purpose

This SOP outlines the procedure for establishing and evaluating system suitability criteria for analytical methods developed and validated by the Analytical Method Development (AMD) department. System suitability ensures that analytical

systems are performing optimally and that results are reliable and reproducible.

2. Scope

This SOP applies to all chromatographic and spectroscopic methods developed within the AMD department where system suitability tests are required before and/or during sample analysis, including but not limited to HPLC, GC, UPLC, and UV-Visible spectroscopy.

3. Responsibilities

  • Analytical Scientist: Identifies and sets preliminary system suitability parameters during method development.
  • Method Validation Analyst: Evaluates parameters during method validation to finalize suitability criteria.
  • QA Reviewer: Reviews and approves finalized system suitability specifications and their application in method SOPs.
  • Documentation Officer: Ensures proper recording of suitability data in method protocols and reports.
See also  Analytical Method Development: SOP for Color Uniformity Analysis in Coated Tablets - V 2.0

4. Accountability

The Head of AMD is accountable for reviewing and authorizing system suitability standards and ensuring their compliance with regulatory requirements and scientific rigor.

5. Procedure

5.1 Understanding System Suitability

  1. System suitability is a series of tests to verify that the system performance is adequate for the intended analysis.
  2. It serves as a prerequisite before beginning the sample analysis or batch release.

5.2 Common System Suitability Parameters

  • Retention Time (RT): Time taken for the analyte peak to elute.
  • Resolution (Rs): Measure of separation between adjacent peaks. Minimum acceptable value: Rs ≥ 2.0.
  • Theoretical Plates (N): Column efficiency. Higher value indicates better separation.
  • Tailing Factor (Tf): Peak symmetry. Ideal range: 0.8–1.5.
  • Relative Standard Deviation (%RSD): For replicate injections. Acceptable limit: ≤ 2.0%.
  • Capacity Factor (k’): Relates to retention and column efficiency.

5.3 Establishing System Suitability Criteria

  1. During method development, record multiple injections of the analyte standard.
  2. Evaluate RT, Rs, Tf, N, and %RSD from the injections.
  3. Identify average and standard deviation values across runs and analysts.
  4. Determine appropriate limits by considering:
    • Regulatory expectations (e.g., ICH Q2(R1))
    • Analytical variability
    • Method criticality and complexity
See also  Analytical Method Development: SOP for LC-MS/MS Method Development in Impurity Profiling - V 2.0

5.4 Integration with Validation Activities

  1. Confirm the reliability of system suitability criteria during intermediate precision and robustness validation runs.
  2. Record all parameter readings in a dedicated system suitability log (Annexure-1).

5.5 Application in Routine Analysis

  1. System suitability criteria must be mentioned in the final test method SOP.
  2. Prior to sample analysis, verify that all parameters are within acceptance limits.
  3. If any parameter fails:
    • Investigate the cause (e.g., column aging, mobile phase instability).
    • Recalibrate or recondition the system.
    • Do not proceed with sample injections until criteria are met.

5.6 Documentation

  1. Use Annexure-1 to log system suitability evaluations for each method developed.
  2. Include chromatograms, calculation spreadsheets, and electronic audit trails in method development reports.

6. Abbreviations

  • RT: Retention Time
  • Rs: Resolution
  • N: Theoretical Plates
  • Tf: Tailing Factor
  • RSD: Relative Standard Deviation
  • ICH: International Council for Harmonisation
See also  Analytical Method Development: SOP for Performing Solution Stability Studies - V 2.0

7. Documents

  1. Annexure-1: System Suitability Evaluation Log Template
  2. Method Development Worksheet
  3. Validation Report Template

8. References

  • ICH Q2(R1) – Validation of Analytical Procedures
  • USP General Chapter <621> Chromatography
  • FDA Guidance for Industry – Analytical Procedures and Methods Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Alok Sharma Nidhi Patel Dr. Harshita Goyal
Designation Senior Analyst QA Reviewer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: System Suitability Evaluation Log Template

Parameter Limit Observed Value Pass/Fail
Resolution (Rs) ≥ 2.0 2.4 Pass
Tailing Factor (Tf) 0.8–1.5 1.2 Pass
RSD (%) ≤ 2.0 1.1 Pass

Revision History

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Updated acceptance limits and added annexure log Annual Review Dr. Harshita Goyal
01/07/2022 1.0 Initial Issue New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for Stability-Indicating Method Development – V 2.0
Next Post: Analytical Method Development: SOP for Documentation Practices During Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version